secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001818331-23-000030
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.03, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx announces 1-for-33 reverse stock split effective May 4, 2023; two directors not standing for re-election
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-33 ratio approved by Board on April 24, 2023; effective May 4, 2023.
- No fractional shares issued; any fractional share rounded up to nearest whole share.
- CUSIP changes: common stock to 81663L 200; public warrants to 81663L 127.
- Directors Rachel Sherman and Dennis Charney will not stand for re-election at 2023 annual meeting; no disagreement.
- Warrant exercise price adjusted from $11.50 to $379.50 per share; each warrant now exercisable for 1/33 of a share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000030/0001818331-23-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000030/smfr-20230424.htm
  HTML page:      https://secwatch.observer/filing/0001818331-23-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer